Recombinant Macaca nemestrina Interleukin-10 (IL10)

What is Interleukin-10 and what are its primary functions in Macaca nemestrina?

Interleukin-10 (IL-10) is a potent immunosuppressive cytokine with powerful anti-inflammatory activities that make it particularly valuable for research in tolerance induction protocols. In nonhuman primates, including Macaca nemestrina, IL-10 functions primarily to inhibit innate immunity and has been associated with islet allograft tolerance . Mechanistically, IL-10 signals through STAT3 to regulate T follicular helper (Tfh) cell differentiation and germinal center formation . This cytokine plays a crucial role in maintaining immunological balance by suppressing inflammatory responses while simultaneously shaping adaptive immune responses through its effects on lymphocyte development and function.

How does the molecular structure of recombinant Macaca nemestrina IL-10 differ from human IL-10?

The molecular structure of Macaca nemestrina IL-10 shares significant homology with human IL-10, though with important functional differences that researchers should consider. While the search results don't specifically address the exact structural differences between Macaca nemestrina IL-10 and human IL-10, comparative studies with rhesus macaque IL-10 (a closely related species) have demonstrated that recombinant macaque IL-10 exhibits significantly greater potency than human IL-10 in biological assays . This suggests evolutionary adaptations in the molecular structure that affect binding affinity, receptor interactions, or downstream signaling cascades, all of which are critical considerations when designing cross-species experimental systems.

What biological assays are standard for measuring Macaca nemestrina IL-10 activity?

Standard biological assays for measuring Macaca nemestrina IL-10 activity include:

• Mouse mast cell line (MC/9) proliferation assay: IL-10 costimulates MC/9 proliferation in a dose-dependent fashion, providing a quantifiable readout of biological activity .

• LPS-induced septic shock suppression: Functional IL-10 demonstrates capacity to suppress LPS-induced inflammatory responses in vivo .

• Cytokine/chemokine suppression assays: IL-10 activity can be measured by its ability to abrogate LPS-induced secretion of proinflammatory cytokines and chemokines both in vitro and in vivo in nonhuman primates .

• STAT3 phosphorylation assays: As IL-10 signals through STAT3, measuring STAT3 phosphorylation levels following IL-10 treatment provides a direct assessment of receptor engagement and signal transduction .

What expression systems are optimal for producing functional recombinant Macaca nemestrina IL-10?

While the search results don't specifically detail expression systems for Macaca nemestrina IL-10, successful approaches used for rhesus macaque IL-10 can be adapted. For optimal production of functional recombinant IL-10, researchers have successfully employed systems where IL-10 is fused to a mutated hinge region of human IgG1 Fc to generate IL-10/Fc(ala-ala) constructs . This approach not only facilitates purification but significantly extends the circulating half-life of the recombinant protein to approximately 14 days . Expression in mammalian cell systems is generally preferred to ensure proper post-translational modifications and protein folding that are essential for biological activity of complex cytokines like IL-10.

What purification strategies yield the highest purity and biological activity of recombinant Macaca nemestrina IL-10?

Affinity chromatography has proven highly effective for purifying recombinant macaque IL-10 fusion proteins. Using this approach, researchers have achieved approximately 98% homogeneity for rhesus macaque IL-10/Fc(ala-ala) . Critical quality control measures include:

• Endotoxin testing: Ensuring preparations are endotoxin-free (<0.008 EU/μg protein) is essential as endotoxin contamination can severely confound immunological studies .

• Functional validation: Purified IL-10 should be validated through multiple biological activity assays as outlined in FAQ 1.3.

• Size exclusion chromatography: This additional purification step helps eliminate protein aggregates that may affect biological activity or induce unwanted immune responses.

How can researchers effectively design experiments to study IL-10 signaling pathways in Macaca nemestrina cells?

Designing effective experiments to study IL-10 signaling in Macaca nemestrina cells requires:

• Ex vivo cell culture systems: Researchers can efficiently isolate and expand CD4+ T cells from pigtailed macaques using paramagnetic beads coated with anti-CD3 and anti-CD28 antibodies . These primary cells provide an excellent platform for studying IL-10 signaling pathways.

• Transcriptomic analysis: Measuring IL-10-regulated transcripts such as B cell lymphoma 6 protein (BCL-6), induced myeloid leukemia cell differentiation protein (MCL1), and immune checkpoint receptors can provide detailed insights into IL-10 signaling pathways .

• Phospho-flow cytometry: This technique allows for single-cell resolution analysis of STAT3 phosphorylation in response to IL-10 stimulation across different immune cell subsets.

• Cell transformation approaches: For long-term studies, T cells can be transformed with Herpesvirus saimiri and maintained in culture for several months, providing a stable system for studying chronic effects of IL-10 signaling .

How does IL-10 contribute to viral reservoir establishment in SIV-infected macaques?

IL-10 plays a multifaceted role in viral reservoir establishment in SIV-infected macaques through several mechanisms:

• Maintenance of target cell populations: IL-10 contributes to maintaining a pool of target cells in lymphoid tissue that serve as a niche for viral persistence . Specifically, plasma IL-10 and transcriptomic signatures of IL-10 signaling correlate with cell-associated SIV-DNA content within lymph node CD4+ memory subsets, including Tfh cells .

• Spatial association with infected cells: In ART-treated rhesus macaques, cells harboring SIV-DNA (detected by DNAscope) are preferentially found in the lymph node B cell follicle in proximity to IL-10, suggesting a direct relationship between IL-10 expression and viral reservoir maintenance .

• Regulation of germinal center dynamics: IL-10 influences germinal center formation and Tfh cell differentiation, creating microenvironments that support persistent viral infection .

This evidence positions IL-10 as a key factor in establishing and maintaining viral reservoirs, with important implications for HIV cure strategies.

What experimental evidence supports targeting IL-10 as a strategy to reduce viral reservoirs?

Several lines of experimental evidence support targeting IL-10 as a strategy to reduce viral reservoirs:

• In vivo neutralization studies: Neutralization of soluble IL-10 in ART-treated, SIV-infected macaques reduced B cell follicle maintenance and, consequently, decreased lymph node memory CD4+ T cells, including Tfh cells and those expressing PD-1 and CTLA-4 .

• Correlation analyses: During chronic SIV infection, plasma IL-10 levels correlate with cell-associated SIV-DNA content in peripheral blood mononuclear cells, rectal mucosa, and lymph node CD4+ T cells, suggesting that reducing IL-10 could potentially impact viral reservoirs across multiple anatomical sites .

• Persistence of elevated IL-10: Following ART initiation, plasma IL-10 decreases but stabilizes at levels higher than pre-infection, indicating a potential role in ongoing reservoir maintenance despite viral suppression .

These findings collectively suggest that targeting IL-10 signaling to impair CD4+ T cell survival and improve antiviral immune responses may represent a novel approach to limit viral persistence in ART-suppressed individuals.

What techniques are used to measure IL-10 levels and their correlation with SIV viral reservoirs?

Researchers employ several techniques to measure IL-10 levels and correlate them with SIV viral reservoirs:

• Plasma IL-10 quantification: Enzyme-linked immunosorbent assays (ELISAs) can measure plasma IL-10 levels, which in SIV-infected macaques have been reported at 19.96 ± 2.481 pg/mL during chronic infection compared to 8.32 ± 0.7849 pg/mL pre-infection .

• Transcriptomic analysis: Measuring IL-10-regulated transcripts in lymphoid tissues provides insights into IL-10 signaling activity .

• Immunohistochemistry: The percentage area of lymph node B cell follicles that stains positive for IL-10 can be quantified (4.765% ± 1.137% area in chronically infected vs. 1.986% ± 0.2073% area in uninfected macaques) .

• Correlation with viral measurements: Cell-associated SIV-DNA content in various compartments is measured using PCR-based approaches and correlated with IL-10 levels .

• DNAscope: This technique allows visualization of cells harboring SIV-DNA in tissue sections, which can be co-localized with IL-10 expression .

How can recombinant Macaca nemestrina IL-10 be utilized in transplantation research models?

Recombinant Macaca nemestrina IL-10 can be utilized in transplantation research through several approaches:

• Supplemental immunotherapy: The powerful anti-inflammatory and immunosuppressive activities of IL-10 make it attractive for supplemental therapy in translational tolerance induction protocols . Administration of recombinant IL-10 could potentially enhance graft survival and promote tolerance.

• Ex vivo treatment of grafts: Treating donor tissues with IL-10 prior to transplantation may reduce immunogenicity and improve acceptance.

• Combined approaches: IL-10 therapy can be combined with conventional immunosuppressants, potentially allowing dose reduction of the latter and minimizing side effects.

• Genetic modification strategies: Cells used for transplantation could be genetically modified to express IL-10, creating a local immunosuppressive environment around the graft.

This application is supported by evidence that IL-10 has been associated with human stem cell and nonhuman primate islet allograft tolerance with elevated serum IL-10, and that systemic IL-10 therapy enhanced pig islet survival in mice .

What are the differences in experimental design when studying acute versus chronic effects of IL-10 in immune modulation?

Studying acute versus chronic effects of IL-10 requires different experimental approaches:

For chronic studies, the extended half-life of IL-10/Fc fusion proteins (approximately 14 days) makes them particularly suitable , while acute studies may utilize native IL-10 with more frequent dosing.

How can ex vivo expanded Macaca nemestrina T cells be used to study IL-10 effects on immune regulation?

Ex vivo expanded Macaca nemestrina T cells provide an excellent model system for studying IL-10's immune regulatory effects:

• Isolation and expansion protocol: CD4+ T cells can be isolated using the 'Dynal CD4 Positive Isolation Kit' and expanded using paramagnetic beads coated with anti-CD3 and anti-CD28 antibodies in the presence of rhIL-2 . This approach yields a 300- to 6000-fold expansion over 24 days .

• Long-term culture systems: T cells can be transformed with Herpesvirus saimiri and maintained in culture for several months, enabling long-term IL-10 exposure studies .

• Modulation of IL-10 signaling: Researchers can manipulate IL-10 signaling through addition of recombinant IL-10, IL-10 receptor blocking antibodies, or STAT3 inhibitors.

• Functional readouts: Effects can be assessed by measuring changes in T cell phenotype (flow cytometry), cytokine production (ELISA, intracellular cytokine staining), proliferation, and gene expression profiles.

• Susceptibility to viral infection: These expanded T cells can be productively infected with SIV, allowing for studies of how IL-10 affects viral replication and persistence .

What strategies can overcome the challenge of IL-10's short half-life in experimental systems?

Several strategies can effectively address IL-10's naturally short half-life:

• Fc fusion proteins: Fusion of IL-10 to a mutated hinge region of human IgG1 Fc (IL-10/Fc(ala-ala)) extends the circulating half-life to approximately 14 days, making it suitable for long-term studies .

• PEGylation: Chemical modification of IL-10 with polyethylene glycol can reduce renal clearance and extend half-life.

• Sustained release formulations: Encapsulation in biodegradable polymers or liposomes can provide controlled release over extended periods.

• Gene therapy approaches: Viral vectors encoding IL-10 can be used to achieve sustained local production in specific tissues.

• Cell-based delivery: Engineering cells to secrete IL-10 continuously can provide localized, sustained delivery.

The choice of approach depends on the specific research questions, with Fc fusion being particularly well-documented for macaque IL-10 .

What are the critical quality control parameters for ensuring consistency in recombinant Macaca nemestrina IL-10 preparations?

Critical quality control parameters include:

• Endotoxin levels: Preparations must be endotoxin-free (<0.008 EU/μg protein) to avoid confounding experimental results through TLR4 activation .

• Protein purity: Affinity chromatography should achieve approximately 98% homogeneity, confirmed by SDS-PAGE and size exclusion chromatography .

• Biological activity: Functional assays including mouse mast cell line MC/9 proliferation, suppression of LPS-induced responses, and STAT3 phosphorylation should be performed on each batch .

• Protein concentration: Accurate quantification using validated methods (BCA, Bradford assay, or amino acid analysis).

• Storage stability: Assessment of activity retention under different storage conditions and after freeze-thaw cycles.

• Batch-to-batch consistency: Comparative analysis between production lots using standardized assays.

These parameters ensure experimental reproducibility and valid interpretation of results when working with recombinant Macaca nemestrina IL-10.

How can researchers differentiate between direct IL-10 effects and secondary downstream consequences in complex experimental systems?

Differentiating direct IL-10 effects from secondary downstream consequences requires sophisticated experimental approaches:

• Temporal analysis: Examining early versus late responses after IL-10 exposure can help distinguish direct signaling events from secondary effects.

• Cell-specific knockout models: Using CRISPR/Cas9 to eliminate IL-10 receptors on specific cell populations can isolate direct versus indirect effects.

• Signaling inhibitors: Selectively blocking STAT3 or other downstream pathways can help delineate which effects require direct IL-10 signaling.

• Transcriptomics with temporal resolution: RNA-seq at multiple timepoints after IL-10 exposure can identify primary response genes versus secondary transcriptional changes.

• Co-culture systems with selective IL-10R blockade: Allowing only certain cell populations to respond to IL-10 in mixed cultures can reveal cell-specific direct effects.

• In vivo cell depletion studies: Removing specific cell populations prior to IL-10 administration can reveal which effects require those cells as intermediaries.

This multi-faceted approach is essential for understanding the complex immunoregulatory network controlled by IL-10, particularly in the context of SIV infection models or transplantation studies.